Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fast Forward And Myelin Repair Foundation: Two Routes To New MS Drugs

Apr 24 2012

• By Alex Lash

Related Content

A More Integrated Approach To Looking At GPCR Signaling

Oct 01 2011

MS Boon: Many Drugs On The Way, But Will Payors Swallow The Cost?

Apr 23 2012

Back To School: Big Pharmas Test New Models For Tapping Academia

Feb 01 2011

Related Companies

Novartis AG

Fast Forward Pharmaceuticals BV

Medco Health Solutions Inc.

Merck KGaA

Apitope Technology (Bristol) Ltd

Amplimmune, Inc.

Athersys, Inc.

Concert Pharmaceuticals, Inc.

Five Prime Therapeutics, Inc.

Lineagen Inc.

Provid Pharmaceuticals Inc.

Elan Corporation

Case Western Reserve University

Cleveland Clinic

National Institutes of Health

Northwestern University

Northwestern University

Stanford University

University of Chicago

Biogen, Inc.

Cystic Fibrosis Foundation

Additional Topics

Strategy Clinical Trials Deals Research & Development BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window